Hello Fellow Stock Traders, Here's a Technical Analysis of BMRI!
After successfully overcoming a significant resistance area, BMRI (Bank Mandiri) experienced a subsequent pullback, thereby establishing a new support level. Analyzing the trend perspective, it is observed that BMRI's price movement surged above the EMA 34 Line, which is a promising indicator of a bullish trend.
Additionally, the stock has formed a symmetrical triangle pattern, accompanied by an impulsive breakout represented by a bullish candlestick formation. Such patterns typically imply potential upward momentum and are considered positive signs for further price appreciation.
Furthermore, the MACD (Moving Average Convergence Divergence) indicator has displayed a hidden bullish divergence, indicating the possibility of the ongoing bullish trend extending further.
In summary, the technical analysis of BMRI reveals multiple favorable factors, including the breach of a substantial resistance area, a bullish trend indicated by the EMA 34 Line, a symmetrical triangle pattern breakout, and the hidden bullish divergence on the MACD. Traders and investors may interpret these signals as potential indications of an upward continuation in BMRI's price movements. As always, prudent risk management practices should be employed before making any investment decisions.
It is essential to note that the analysis will no longer hold validity once the target/support area is reached.
Please support the channel by engaging with the content, using the rocket button, and sharing your opinions in the comments below!
Disclaimer: Please note that this analysis is solely for educational purposes and should not be considered as a recommendation to take a long or short position on BMRI .
Note
The incoming Earning Report this Weekend May affect the stock price movement.
Trade closed: target reached
Finally hit the first target after several months of waiting lol
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.